A V Dontsov Selected Research

Ala(2)-Arg(6)- enkephalin-Leu

1/2017	[THE INFLUENCE OF DEFICIT OF ENDOGENOUS NEUROPEPTIDES ON THE CLINICAL COURSE OF CORONARY HEART DISEASE].
1/2015	[THE ANTIOXIDANT EFFECT OF DALARGIN IN PATIENTS WITH CORONARY HEART DISEASE AND METABOLIC SYNDROME].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A V Dontsov Research Topics

Disease

3	Coronary Disease (Coronary Heart Disease) 01/2017 - 01/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2015
2	Hyperinsulinism (Hyperinsulinemia) 01/2017 - 01/2016
1	Disease Progression 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Depressive Disorder (Melancholia) 01/2016
1	Insulin Resistance 01/2016
1	Necrosis 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015

Drug/Important Bio-Agent (IBA)

2	Ala(2)-Arg(6)- enkephalin-LeuIBA 01/2017 - 01/2015
2	CytokinesIBA 01/2017 - 01/2016
1	EndorphinsIBA 01/2017
1	NeuropeptidesIBA 01/2017
1	CholesterolIBA 01/2016
1	EnzymesIBA 01/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	oxidized low density lipoproteinIBA 01/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015
1	Superoxide DismutaseIBA 01/2015
1	AntioxidantsIBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2017 - 01/2015